- A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALN-TTRSC04 in Healthy Subjects
- Amyloidosis TTR Flow Reserve Evaluation
- An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy
- Analysis of the Instestinal Microbiome of Patients With Transthyretin Amyloidosis
- Assessment of the Prevalence of TTR Amyloid Neuropathy in a Population of Patients With Neuropathy of Unknown Aetiology
- ATTR-Cardiomyopathy Stabilization Following Tafamidis Therapy
- Autonomic Evaluation of Patients With Hereditary Amyloidotic Cardiomyopathy: Hereditary Amyloidotic Heart Disease
- Bern Cardiac Amyloidosis REgistry (B-CARE)
- Biomarker for Transthyretin-Related Familial Amyloidotic Polyneuropathy (BioTRAP)
- Burden of Disease Study In Patients With Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP) orTransthyretin Cardiomyopathy (TTR-CM) And Caregivers
- Cardiac Amyloidosis Screening at Trigger Finger Release
- carDIo-ttranSSfOrm nucLEar Imaging Study
- Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
- ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
- DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis
- Early Detection of Neuropathy in ATTRv
- Effect of Radiotherapy on ATTR Cardiac Amyloidosis : a Proof of Concept Study
- Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy
- Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
- ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)
- Epidemiological Analysis for the Hereditary Transthytetin-related Amyloidosis (hATTR)
- Evaluation of a Claims-based Algorithm for the Identification of Transthyretin-mediated Amyloidosis (ATTR) Amyloidosis in Medical Records
- Evuzamitide as SPECT/CT Imaging Agent for Diagnosis of Transthyretin Amyloidosis
- Exercise Effect on Transthyretin Stability
- Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR)
- Expanding the Biomarkers in Familial Amyloid Neuropathy: MRI and Motor Unit Estimation by Electrophysiological Study
- Global Prevalence of ATTR-CM in Participants With HFpEF
- HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)
- Imaging for the Evaluation of Transthyretin Cardiac Amyloidosis Prevalence of Patients Over 65 Hospitalized in Cardiology Wards (the IMPACT Study)
- ION-682884 in Patients With TTR Amyloid Cardiomyopathy
- Left Atrial Strain and Supraventricular Arrhythmia Burden in Cardiac Light Chain Amyloidosis Following Chemotherapy
- Longitudinal Changes in Left and Right Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis
- Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis
- Open-Label Extension Assessing Long Term Safety and Efficacy of IONIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP)
- Open-Label Study of AG10 in Patients With Cardiomyopathy
- Patient-Reported Outcome Measures in Wild-Type and Variant Cardiac Transthyretin Amyloidosis
- Penn Biobank Return of Research Results Program
- Positron Emission Tomography / Magnetic Resonance Imaging in Aortic Stenosis
- Prevalence of Transthyretin Amyloidosis in Hypertrophic Cardiomyopathy
- Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis
- Prevalence of Wild-Type Transthyretin Cardiac Amyloidosis Among Patients Undergoing Carpal Tunnel Release Surgery – A Prospective Study
- Prognostic Value of Echocardiographic Parameters Based on Machine Learning Approach
- Quantitative Analysis of Myocardial Uptake of Bone Radiopharmaceuticals in Patients With Cardiac ATTR Amyloidosis
- Safety and Efficacy Study of Doxycycline/UrsoDeoxyCholicAcid on Disease Progression in ATTR Amyloidosis
- Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis
- Screening for Systemic Amyloidosis Via the Ligamentum Flavum
- Screening of ATTRwt in Patient With Advanced AV-Block Undergoing Pacemaker Implantation
- SGLT2 Inhibitors in ATTR
- Short-term Effects of TOLCAPONE on Transthyretin Stability in Subjects With Leptomeningeal TTR Amyloidosis (ATTR)
- Study of SOM0226 in Familial Amyloid Polyneuropathy
- Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-2001 in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN)
- The Effect of Diflunisal on Familial Amyloidosis
- The Effect Of Tafamidis For The Transthyretin Amyloid Polyneuropathy Patients With V30M Or Non-V30M Transthyretin
- The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy Patients
- The Effect of Tafamidis on Transthyretin Stabilization, Safety, Tolerability and Efficacy in Transthyretin Amyloid Polyneuropathy Patients
- The Effect of Trimetazidine on Mitochondrial Function, Myocardial Performance, and Invasive Hemodynamics in Patients Diagnosed With Wild-Type Transthyretin Cardiac Amyloidosis
- The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant
- Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) in Patients With Idiopathic Peripheral Neuropathy
- Transthyretin-Associated Amyloidosis Outcome Survey (THAOS)
- Unmasking the Prevalence of AC in an Unselected Echocardiographic Population
- Vyndaqel Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Clinical Trials
- Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial
- Assess Safety and Efficacy of VAD044 in HHT Patients
- Bevacizumab In Hereditary Hemorrhagic Telangiectasia
- Counseling Intervention in Hereditary Hemorrhagic Telangiectasia in the COVID Era.
- Development of a Quality of Life Measurement Scale in Hereditary Haemorrhagic Telangiectasia (HHT) Disease.
- Diet and Hereditary Haemorrhagic Telangiectasia
- Doxycycline for Hereditary Hemorrhagic Telangiectasia
- Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
- Evaluation of Obstetrical and Neonatal Complications in Hereditary Haemorrhagic Telangiectasia (HHT)
- Evaluation of Video-assisted Instructions of Nasal Self-packing in Patients With HHT
- Frequency of Common Medical Conditions in People With and Without HHT
- Genotype Expression and Phenotype of Endothelial Cells, Carrying an ACVRL1, ENG or SMAD4 Mutation, in Response to BMP9 for the Identification of New Therapeutic Targets in Hereditary Haemorrhagic Telangiectasia
- Hereditary Haemorrhagic Telangiectasia Flight Safety Study
- Hereditary Hemorrhagic Telangiectasia (HHT) Research Outcomes Registry
- Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic Telangiectasia
- Intranasal Bevacizumab for HHT-Related Epistaxis
- Iron Deficiency and Hereditary Haemorrhagic Telangiectasia
- MRA With Feraheme in HHT
- Pazopanib Effects on Bleeding in Hereditary Hemorrhagic Telangiectasia
- Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia
- Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia
- Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic Telangiectasia
- Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study
- Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients
- Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT)
- Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia
- Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
- Recurrence of Hereditary Hemorrhagic Telangiectasia (HHT) After Liver Transplantation
- Sirolimus for Nosebleeds in HHT
- Study of the Natural History and Genotype-Phenotype Correlations of Hereditary Hemorrhagic Telangiectasia Patients
- Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
- Tacrolimus Crossover Trial for Hereditary Hemorrhagic Telangiectasia (HHT)
- Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
- Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia
- Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept
- Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
- Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT
- Vitamin D and Hereditary Haemorrhagic Telangiectasia
- A Bioelectric Dressing for Post De-Roofing Treatment of HS
- A Double-blind Placebo-controlled Randomized Trial Evaluating the Efficacy and Safety of a Novel HSP90 Inhibitor (RGRN-305) in the Treatment of Moderate to Severe Hidradenitis Supppurativa.
- A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- A National Registry For Patients With Hidradenitis Suppurativa
- A Pilot Study to Explore the Role of Gut Flora in Acne
- A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa
- A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa
- A Randomized Controlled Trial Evaluating the Efficacy of Intralesional Triamcinolone in Hidradenitis Suppurativa.
- A Randomized, Controlled Trial Comparing the Use of a Biodegradable Temporizing Matrix to Cadaver Skin in the Reconstruction of Hidradenitis Suppurativa Excisions
- A Single and Multiple Ascending Dose Trial of KT-474 in Healthy Adult Volunteers and Patients With Atopic Dermatitis (AD) or Hidradenitis Suppurativa (HS)
- A Single Center, Prospective Clinical Trial of Intravenous Ertapenem in the Treatment of Hurley Stage II or III Hidradenitis Suppurativa
- A Small Clinical Study: Photodynamic Therapy to Treat Hidradenitis Suppurativa
- A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial
- A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa
- A Study of Bermekimab in Patients With Hidradenitis Suppurativa
- A Study of LY3041658 in Adults With Hidradenitis Suppurativa
- A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease Symptoms
- A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa
- A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy
- A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS)
- A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
- A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With Hidradenitis Suppurativa
- A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa
- A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
- A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
- A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa
- A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS
- A Study to Test the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
- A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa.
- A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
- A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa
- Activation of a Cutaneous Inflammasome in the Skin of Hidradenitis Suppurativa Patients
- An Alternative Dose Interval Study in Participants With Hidradenitis Suppurativa Receiving Brodalumab
- An Investigation Into the Efficacy of Provodine Topical Cream as Compared to 10% Benzoyl Peroxide Wash for the Treatment of Hidradenitis Suppurativa.
- Anakinra as a Treatment for Hydradenitis Suppurativa
- Anakinra in Hidradenitis Suppurativa
- Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
- ATI-450 vs Placebo in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)
- Autophagy Dysfunction in Hidradenitis Suppurativa
- Battlefield Acupuncture for Pain in Hidradenitis Suppurativa
- Biomarkers In Hidradenitis Suppurativa Participants Receiving Brodalumab
- Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab.
- Botulinum Toxin Therapy in Hidradenitis Suppurativa
- Canadian Humira Post Marketing Observational Epidemiological Study : Assessing Humira Real-life Effectiveness and Impact on HS Burden of Illness
- Clinical and Biological Characteristics of Hidradenitis Suppurativa
- Complement C5a Receptors in Hidradenitis Suppurativa
- Control of Hidradenitis Suppurativa of the Underarms After Combination Deroofing and Laser
- Cost-effectiveness of Adalimumab and Surgery vs Adalimumab in HS
- Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa
- Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients – a Multi cOuNtry studY in Real Life Setting
- Efficacy and Safety of Efalizumab in the Treatment of Moderate-Severe Hydradenitis Suppurativa
- Efficacy and Safety of Infliximab Biosimilar in Treatment of Resistant Hidradenitis Suppurativa
- Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
- Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis Suppurativa
- Efficacy and Safety Study of IFX-1 in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)
- Efficacy and Tolerability of a Fractional Ablative Erbium Laser for Axillary Scarring for Hidradenitis Suppurativa Patients
- Etanercept in Hidradenitis Suppurativa
- Evaluating the Effect of a Written Action Plan on Comfort and Understanding of Hidradenitis Suppurativa
- Evaluation of Cutaneous and Circulating Inflammatory Biomarkers in Hidradenitis Suppurativa and Atopic Dermatitis
- Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa
- Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa
- Exploratory Trial Evaluating Cosentyx (Secukinumab) for Patients With Moderate-to-Severe Hidradenitis Suppurativa
- Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa
- Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin
- Gentian Violet Treatment for Hidradenitis Suppurativa
- Guselkumab for Hidradenitis Suppurativa, a Mode of Action Study.
- Hidradenitis – an Analysis of Genetic Traits and Linkages in Families
- Hidradenitis Suppurativa (HS) Tunneling Wounds
- Hidradenitis Suppurativa Mail Survey
- Hidradenitis Suppurativa Patient Experience With Humira Treatment
- Hidradenitis Suppurativa Phase 2b Pivotal Study of Izokibep
- Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository
- Hidradenitis Suppurativa Wound Care
- Hidradenitis Suppurativa Written Action Plan
- HidraWear AX HS Study
- Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa
- Impact of Hidradenitis Suppurativa on Quality of Life Functions
- Intense Pulsed Light Therapy for Hidrosadenitis Suppurativa
- Intralesional Diode Laser Treatment of Fistulas in Hidradenitis Suppurativa
- Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions
- Low Dose Radiotherapy for Advanced Hidradenitis Suppurativa
- LTX-109 as Treatment for Hidradenitis Suppurativa
- MABp1 IN HIDRADENITIS SUPPURATIVA REFRACTORY TO ADALIMUMAB
- Metformin for the Treatment of Hidradenitis Suppurativa (HS)
- Microwave Ablation in Mild Axillary Hidradenitis Suppurativa
- Mindfulness Training Hidradenitis Suppurativa (HS)
- Molecular Characteristics of Brodalumab in Hidradenitis Suppurativa
- Negative Pressure Wound Therapy With Instillation for Treatment of Hidradenitis Suppurativa
- Nutritional Status and Hidradenitis Suppurativa (Acne Inversa)
- Observational Study Evaluating Long-Term Safety and Effectiveness of Humira in Patients With Hidradenitis Suppurativa
- Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa
- Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
- Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa
- Orismilast for the Treatment of Mild to Severe Hidradenitis Suppurativa
- Perforator Flaps for Axillary Hidradenitis Suppurativa
- Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa
- Post Marketing Observational Study (PMOS) to Assess Quality of Life in Swedish Hidradenitis Suppurativa (HS) Patients
- Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects
- Quality of Life After Wide Surgical Excision in Patients With Hidradenitis Suppurativa
- Reconstructions With Back Donor Site Flaps and Validation of Quality of Life Scales
- Regulation of Inflammatory Genes in Hidradenitis Suppurativa
- Relationships Among Inflammation, Physical and Mental Health in Subjects With Chronic Inflammatory Physical Diseases.
- Replicative Stress in Hair Follicle Stem Cells and Pathogeny of Hidradenitis Suppurativa
- Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-Surgically
- Safety and Efficacy of Laser Therapy in Gynaecology
- Safety and Pharmacokinetics of Repeat Doses of CSL324 in Subjects With Hidradenitis Suppurativa and Palmoplantar Pustulosis
- Secukinumab Global MAP Cohort for Adult Patients With Hidradenitis Suppurativa (HS)
- Short-term Safety, Efficacy and Mode of Action of Apremilast in Moderate Suppurative Hidradenitis
- Single Center Study of Apremilast for the Treatment of Hidradenitis Suppurativa
- Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Suppurativa
- Study of Efficacy and Safety of Investigational Treatment in Patients With Hidradenitis Suppurativa
- Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa
- Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)
- Study of the Effect of Fostamatinib Upon Cutaneous Inflammation in the Setting of Hidradenitis Suppurativa
- Study of the Immunomodulation in the Hidradenitis Suppurativa and Evaluation of a New Therapeutic Strategy
- Study on the Effect of NdYag Laser for the Treatment of Hidradenitis Suppurativa
- Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis Suppurtativa
- Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical Deroofing
- Study to Evaluate of the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa
- Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis Suppurativa
- Studying Complement Inhibition in Patients With Moderate to Severe Hidradenitis Suppurativa
- surgiGRAFTnano for Hidradenitis Suppurativa
- The Myriad™ Registry
- The Ohio State University Dermatology Biorepository
- The Role of Host-microbiota Interplay in Hidradenitis Suppurativa Pathogenesis
- This is a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).
- To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa
- To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa
- To Determine the Efficacy of a Laser Device for the Treatment of Hidradenitis Suppurativa
- Topical Ruxolitinib 1.5% for HS
- Treatment of Hidradenitis Suppurativa Using Etanercept
- Treatment of Hidradenitis Suppurativa With Eth 755nm Alexandrite Laser
- Treatment of Moderate Hidradenitis Suppurativa
- Trial Comparing Efficacy of Treatments for Hidradenitis Suppurativa
- Trial to Determine the Immunomodulatory Activity of PTM-001 in Patients With Hidradenitis Suppurativa
- Wet-to-dry vs Petrolatum & Non-stick Dressings After Hidradenitis Suppurativa Surgery
- Wound Dressings for Hidradenitis Suppurativa
- Wound Etiology and Healing Study
- A Study of the Genetic Analysis of Brain Disorders
- Clinical and Genetic Studies on Holoprosencephaly
- Retrospective Study Using Next Generation Sequencing (NGS) on Biological Samples to Improve Genetic Counseling for Patients With Previously Explored Craniofacial Midline Defects.
- Study of the Experiences and Needs of Parents Continuing a Pregnancy Following a Prenatal Diagnosis of Holopresencephaly
- A Phase Ⅲ Study of JR-141 in Patients With Mucopolysaccharidosis II
- A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase®
- A Study of DNL310 in Pediatric Subjects With Hunter Syndrome
- A Study of GC1111 in Hunter Syndrom Patients
- A Study of JR-141 in Patients With Mucopolysaccharidosis II
- A Study of JR-141 in Patients With Mucopolysaccharidosis II
- A Study of JR-141 in Patients With Mucopolysaccharidosis Type II
- A Study of Potential Treatment-Responsive Biomarkers in Hunter Syndrome
- A Study to Improve the Awareness of Mucopolysaccharidosis Type II in Brazil
- A Study to Test the Possibility of Cross Reaction Induced by the Idursulfase Drug to GSK2788723
- An Extension Study of JR-141 in Patients With Mucopolysaccharidosis II
- An Extension Study of JR-141-BR21 in Patients With Mucopolysaccharidosis II
- Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-913 in Subjects With MPS II
- Biomarkers for Hunter Syndrome
- Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome
- Hunter Outcome Survey (HOS)
- Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II)
- Intensive Pharmacovigilance Program for Elaprase (SHP ELA-701)
- Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Age
- Long-term Follow-Up for RGX-121
- Mucopolysaccharidosis Type II Natural History
- Mucopolysaccharidosis Type II Observational
- Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II)
- Phase I/II Study of Retroviral-Mediated Transfer of Iduronate-2-Sulfatase Gene Into Lymphocytes of Patients With Mucopolysaccharidosis II (Mild Hunter Syndrome)
- RGX-121 Gene Therapy in Children 5 Years of Age and Over With MPS II (Hunter Syndrome)
- RGX-121 Gene Therapy in Patients With MPS II (Hunter Syndrome)
- Safety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter Syndrome
- Safety and Efficacy of Hunterase
- Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System (CNS) Involvement and Who Are Currently Receiving Treatment With Elaprase®
- Study of Idursulfase-beta (GC1111) in Hunter Syndrome
- Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094
- The Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) Patients
- To Evaluate the Safety and Efficacy of GC1111 (Recombinant Human Iduronate-2-sulfatase) in Hunter Syndrome Patients
- [PETDE10] Imaging of PDE10A Enzyme Levels in Huntington’s Disease Gene Expansion Carriers and Healthy Controls With PET.
- 31P-MRS and Huntington Disease
- A Biospecimen and Clinical Data Study on Patients With Alzheimer’s, Multiple Sclerosis, Parkinson’s, and Huntington’s, for Drug & Biomarker Discovery
- A Clinical Study in Participants With Huntington’s Disease (HD) to Assess Efficacy and Safety of Three Oral Doses of Laquinimod
- A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington’s Disease
- A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease
- A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan
- A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects
- A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function
- A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects
- A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Versus Placebo for Symptomatic Treatment in Patients With Huntington’s Disease
- A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers
- A Phase II Safety and Tolerability Study With SEN0014196
- A Pilot Evaluation of Mindfulness-based Cognitive Therapy for People With Huntington’s Disease
- A Pilot Study Assessing Impulsivity in Patients With Huntington’s Disease on Xenazine (Tetrabenazine)
- A Pilot Study of Nutritional Status in Patients With Huntington’s Disease
- A Pre-Cellular Therapy Observational Study in Early Huntington’s Disease
- A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers
- A Repeat Dose Study in Healthy Volunteers Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK356278
- A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease
- A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington’s Disease
- A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin
- A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine)
- A Study in Subjects With Late Prodromal and Early Manifest Huntington’s Disease (HD) to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Pepinemab (VX15/2503)
- A Study of Pridopidine (ACR16) for the Treatment of Patients With Huntington’s Disease
- A Study of the Novel Drug Dimebon in Patients With Huntington’s Disease
- A Study of Treatment With Pridopidine (ACR16) in Patients With Huntington’s Disease
- A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SAGE-718 Oral Solution in Patients With Huntington’s Disease – Part B
- A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users
- A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington’s Disease (HD)
- A Study to Evaluate the Effect of SAGE-718 on Functioning Capacity in Participants With Huntington’s Disease
- A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Patients With Manifest Huntington’s Disease
- A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington’s Disease (HD)
- A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington’s Disease
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7234292 (ISIS 443139) in Huntington’s Disease Patients Who Participated in Prior Investigational Studies of RO7234292 (ISIS 443139)
- A Study to Investigate the Pharmacokinetics and Pharmacodynamics of RO7234292 (RG6042) in CSF and Plasma, and Safety and Tolerability Following Intrathecal Administration in Patients With Huntington’s Disease
- A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease
- Accelerated Diffusion MRI for Diagnosis of Hungtington Disease
- Adapted Physical Activity Effect on Abilities and Quality of Life of Huntington Patients and Relatives During Rehab Stay
- An Exploratory Clinical Trial in Early Stage Huntington’s Disease Patients With SEN0014196
- An Extension of the HORIZON Protocol Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington Disease
- An Open Label Study of ANX005 in Subjects With, or at Risk for, Manifest Huntington’s Disease
- An Open-Label Extension Study to Evaluate Long-Term Safety and Tolerability of RO7234292 (RG6042) in Huntington’s Disease Patients Who Participated in Prior Roche and Genentech Sponsored Studies
- Apathy Cure Through Bupropion in Huntington’s Disease
- Assessing Efficacy of Neuropsychiatric Assessment and Treatment Protocols in Huntington’s Disease Patients
- Assessing the Symptomatic Benefit of Acoustic Slow Wave Enhancement in Parkinson Disease
- Atomoxetine and Huntington’s Disease
- Behavioural Problems in Huntington Disease : Analysis and Enhancement of Caregiver and Patient Experience
- Beta Testing of a New Assessment in Huntington’s Disease (HD)
- Bioavailability of Ubiquinol in Huntington Disease
- Biological Sample Collection for Research and Biobanking
- Characterization and Quantification of Motor Speech Disorders in Huntington’s Disease: Identification of Acoustic Markers
- Characterization of the Profile of Dysarthria in Huntington’s Disease, Using the Clinical Evaluation Battery of Dysarthria
- Child to Adult Neurodevelopment in Gene Expanded Huntington’s Disease
- Citalopram to Enhance Cognition in HD
- CKD-504 in SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects
- Clinical Extension Study for Safety and Efficacy Evaluation of Cellavita-HD Administration in Huntington’s Patients.
- Clinical Study to Monitor Plasma Levels of 24OHC in Subject With HD
- Clinicopathological MRI and CSF Correlates in Huntington’s Disease.
- Coenzyme Q10 in Huntington’s Disease (HD)
- Cognitive Assessment Battery (CAB) Beta Study
- Comparison Between [11C]UCB-J and [18F]SynVest-1 PET in HD.
- Cooperative Huntington’s Observational Research Trial
- Couple and Spouse Caregiver in Huntington’s Disease
- Creatine Safety & Tolerability in Huntington’s Disease
- Creatine Safety and Tolerability in Premanifest HD: PRECREST
- Creatine Safety, Tolerability, & Efficacy in Huntington’s Disease (CREST-E)
- Creatine Therapy for Huntington’s Disease
- Dance and Huntington Disease
- Decoding Presymptomatic White Matter Changes in Huntington Disease
- Deep Brain Stimulation (DBS) of the Globus Pallidus (GP) in Huntington’s Disease (HD)
- Deep Brain Stimulation of the Globus Pallidus in Huntington’s Disease
- Deep Brain Stimulation Treatment for Chorea in Huntington’s Disease
- Development of Assessments for Later Stage HD
- Development of the Virtual Unified Huntington’s Disease Rating Scale
- Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy Subjects
- Dose-response Evaluation of the Cellavita HD Product in Patients With Huntington’s Disease
- Dosimetry of [11C]CHDI-180R and [11C]CHDI-626.
- Effect of PBT2 in Patients With Early to Mid Stage Huntington Disease
- Effect of Tetrabenazine on Stroop Interference in HD
- Effects of EGCG (Epigallocatechin Gallate) in Huntington’s Disease (ETON-Study)
- Effects of Lithium and Divalproex`on Brain-Derived Neurotrophic Factor in Huntington’s Disease
- Effects of Music Therapy on Huntington’s Disease
- Efficacy and Safety of SOM3355 in Huntington’s Disease Chorea
- Efficacy and Safety of Tetrabenazine in Chorea
- Efficacy and Safety on SOM3355 in Huntington’s Disease Chorea
- Efficacy of Cognitive Rehabilitation Using Virtual Reality and Computer-based Cognitive Stimulation on Cognitive Impairment Associated to Movement Disorders
- Efficacy of Deutetrabenazine to Control Symptoms of Dysphagia Associated With HD
- Efficacy, Safety and Tolerability of AFQ056 in Patients With Huntington’s Disease in Reducing Chorea
- Electronic-health Application To Measure Outcomes REmotely Clinical Trial
- Energy Balance in Huntington’s Disease. A Multidisciplinary Study Approach for a Complex Problem (BEHD-EM)
- Escalating Dose Study in Healthy Volunteers With SEN0014196
- Evaluating the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington’s Disease
- Evaluating the Relationship of Morphine Consumption and Pain-related Molecules in Hepatic Surgical Patients
- Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects.
- Examination of Quantitative Electroencephalographic (QEEG) Biomarkers in Huntington’s Disease
- Exercise Effects in Huntington’s Disease
- Exploring Computerised Cognitive Training for People With Huntington’s Disease
- Family Health After Predictive Huntington Disease (HD) Testing
- Far Infrared Irradiation for Managing, Control and Treatment of Huntington’s Disease (HD)
- Feasibility and Acceptability of Implementing a Clinic-based Physical Activity Coaching Intervention in People With Premanifest and Early Stage HD
- Feasibility of a Video-oculography in Patients With Huntington’s Disease VOG-HD Study
- Follow-up Measurement of Brain PDE10A Enzyme Levels in Huntington´s Disease Gene Expansion Carriers
- Functional Imaging of Social Cognition in Premanifest Huntington’s Disease
- FuRST 2.0 Cognitive Pre-Testing
- FuRST 2.0 Cognitive Pre-testing – Round 2
- Group Drum-Based Music Therapy Intervention for Parkinson’s Disease/Huntington’s Disease
- HD-Charge: Indirect and Out-of-Pocket Costs of Huntington’s Disease in the United States
- HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington’s Disease
- Healthy Volunteer Positron Emission Tomography (PET) Brain Occupancy Study of a Phosphodiesterase 4 (PDE4) Inhibitor in Huntington’s Disease
- Home-based Transcranial Direct Current Stimulation Open Trial for Behavioral and Cognitive Symptoms in Huntington’s Disease
- Huntington’s Disease 123
- iMagemHTT: FIH Evaluation of Novel Mutant Huntingtin PET Radioligands [¹¹C]CHDI-00485180-R and [¹¹C]CHDI-00485626
- Impact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington Disease
- Individuals Patterns of Disclosure About Huntington s Disease (HD) and the Association With Adaptation to HD
- Is Caffeine an Environmental Modifier in Huntington’s Disease?
- Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.
- Long-Term Study of Cerebral Glucose Metabolism in Huntington’s Disease
- Making HD Voices Heard Pilot Study
- Making Sense of a Positive Genetic Test Result for Huntington Disease
- Measurement and Modification of Threat Interpretation Bias in Neurodegenerative Movement Disorders (Aims 2 & 3)
- Measuring Cortisol Levels in Persons With Parkinson’s (PD)
- Melatonin for Huntington’s Disease (HD) Gene Carriers With HD Related Sleep Disturbance – a Pilot Study
- Memory Disorders Registry
- Metabolomic Study in Huntington’s Disease (METABO-HD)
- MIG-HD: Multicentric Intracerebral Grafting in Huntington’s Disease
- Minocycline in Patients With Huntington’s Disease
- Mitochondrial Biomarkers in Huntington’s Disease
- Move to Improve: Telehealth Exercise to Music for HD
- Multicentric Trial of the Treatment of Huntington’s Disease by Cysteamine (RP103)
- N- Homocysteinylated Huntingtin in Huntington’s Disease
- Natural History Study in Huntington Disease Gene Expansion Carriers (HDGECs) – SHIELD HD
- Neurobiological Predictors of Huntington’s Disease (PREDICT-HD)
- Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and Tiapride
- Neuroprotection by Cannabinoids in Huntington’s Disease
- Nilotinib in Huntington’s Disease
- Non-invasive Brain Stimulation in Huntington’s Disease
- OCTA in Mild Cognitive Impairment and Alzheimer’s Disease
- Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease
- Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120101 in Patients With Huntington’s Disease
- Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120102 in Patients With Huntington’s Disease
- PhI/II Dose-Finding Study to Evaluate BV-101 Striatal Administration in Adults With Early Manifest Huntington’s Disease
- PHysical Activity and Exercise Outcomes in Huntington’s Disease
- Pilot Study of Minocycline in Huntington’s Disease
- PINS Stimulator System for Deep Brain Stimulation in Huntington’s Disease
- Premanifest Huntington’s Disease Extension Study II: Creatine Safety & Tolerability
- Premanifest Huntington’s Disease: Creatine Safety & Tolerability Extension Study
- Preparing for Prevention of Huntington’s Disease (PREVENT-HD)
- PRidopidine’s Outcome On Function in Huntington Disease, PROOF- HD
- Proof of Concept of an Anaplerotic Study Using Brain Phosphorus Magnetic Resonance Spectroscopy in Huntington Disease
- Prospective Huntington At Risk Observational Study
- Prospective Single-Timepoint Huntington’s Disease Biospecimen Collection Study
- Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington’s Disease
- REGISTRY – an Observational Study of the European Huntington’s Disease Network (EHDN)
- Resveratrol and Huntington Disease
- Riluzole in Huntington’s Disease
- Risperidone for the Treatment of Huntington’s Disease Involuntary Movements
- Safety and Efficacy of AMT-130 in European Adults With Early Manifest Huntington Disease
- Safety and Efficacy of Bone Marrow Derived MNCs for Treatment of Cells for the Treatment of Hunting Tons Chorea.
- Safety and Efficacy of Fenofibrate as a Treatment for Huntington’s Disease
- Safety and Efficacy of OMS643762 in Subjects With Huntington’s Disease
- Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington Disease
- Safety and Tolerability of WVE-120101 in Patients With Huntington’s Disease
- Safety and Tolerability of WVE-120102 in Patients With Huntington’s Disease
- Safety and Tolerability Study of Phenylbutyrate in Huntington’s Disease (PHEND-HD)
- Safety and Tolerability Study With VY-HTT01, in Adults With Early Manifesting Huntington’s Disease
- Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington’s Disease
- Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington’s Disease
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 443139 in Participants With Early Manifest Huntington’s Disease
- Social Cognition in Huntington’s Disease: Cognitive Study and Functional and Morphological Imaging
- Study Evaluating The Safety, Tolerability And Brain Function Of 2 Doses Of PF-0254920 In Subjects With Early Huntington’s Disease
- Study Exploring Safety, Pharmacokinetic and Pharmacodynamic of BN82451 in Male Huntington’s Disease Patients
- Study in PRE-manifest Huntington’s Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
- Study of BDNF Pathway Biomarkers in the Cerebrospinal Fluid in Patients With Huntington’s Disease
- Study of Biomarkers That Predict the Evolution of Huntington’s Disease
- Study of Huntington Patients in Connection With European Huntington’s Disease Network (EHDN)
- Study of Memantine to Treat Huntington’s Disease
- Study of Motor Slowing in Parkinson’s Disease by a Computerized Mental Chronometry Paradigm
- Study of WVE-003 in Patients With Huntington’s Disease
- Study To Assess the Safety and Tolerability of Single Ascending Oral Doses of PBF-999 in Healthy Young Male Volunteers
- Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-999 “After Multiple Oral Doses” in Healthy Volunteers
- Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington’s Disease
- Symptomatic Therapy for Patients With Huntington’s Disease
- Synaptic Density and Progression of Huntington’s Disease.
- TEsting METformin Against Cognitive Decline in HD
- The Effect of Video Game Exercise on Dynamic Balance and Gait in Individuals With Huntington’s Disease
- Treadmill Walking in Individuals With Dementia With Lewy Bodies and Huntington’s Disease
- Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon
- Treatment of Huntington’s Chorea With Amantadine
- TREND-HD – A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington’s Disease
- Trial of the Combined Use of Thiamine and Biotin in Patients With Huntington’s Disease
- Ursodiol in Huntington’s Disease
- Using Wearable and Mobile Data to Diagnose and Monitor Movement Disorders
- Utilization of 31P-Nuclear Magnetic Resonance Spectroscopy to Monitor Brain Energy Deficit in Huntington Disease
- Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
- Wearable Sensors for Quantitative Assessment of Motor Impairment in Huntington’s Disease Huntington’s Disease
- Within Subject Crossover Study of Cognitive Effects of Neflamapimod in Early-Stage Huntington Disease
- Working Memory Training in Huntington’s Disease
- A Precision and Accuracy Study of the Codman Valve Position Verification (VPV) System.
- A Registry for Comparing Catheter-Related Infection Rates Among Various Shunt Systems in the Treatment of Hydrocephalus
- A Secondary Study Evaluating Aqueduct’s Smart External Drain (SED)
- A Study Comparing Two Treatments for Infants With Hydrocephalus
- A Study Evaluate Aqueduct’s Smart External Drain
- A Study on the Safety of Hakim Programmable Shunt System
- An Evaluation of a Non-invasive Brain Monitor
- An Evaluation of Non-Invasive ICP Monitoring in Patients Undergoing Invasive ICP Monitoring Via an Intraparenchymal Pressure Monitoring Device
- Assess Specific Kinds of Children Challenges for Neurologic Devices Study
- Assessment of CSF Shunt Flow With Thermal Measurements
- Assessment of CSF Shunt Flow With Thermal Measurements B
- Bactiseal Catheter Safety Registry in China
- Bench Study of Transcutaneous Hydrocephalic Shunt Flow Sensor Alignment Accuracy and Repeatability
- BIS Monitoring of Patients With Hydrocephalus
- Blood and Cerebrospinal Fluid for Pediatric Brain Tumor Research
- Brain Aneurysms: Utility of Cisternal Urokinase Irrigation
- Brain Ultrasound in the Weaning of External Ventricular Leads
- Caregiver Burden and Anxiety in Mothers of Children With Hydrocephalus
- Cerebrospinal Fluid Proteom in Dependence of Intranasal Breast Milk
- Clinical Application and Functionality for an Application for Measurement of Head Circumference.
- Combined Flow and Pressure Study of Craniospinal Dynamic
- Comparison of Continuous Noninvasive and Invasive Intracranial Pressure Measurement–Celda Infusion Subprotocol
- Comparison of Optic Nerve Sheath Diameter Measured by Ultrasonography Before and After Ventriculoperitoneal Shunt Surgery in Adult Patients With Hydrocephalus
- Comparison of Optic Nerve Sheath Diameter on Retrobulbar Ultrasonography Before and After Drainage of Cerebrospinal Fluid in Pediatric Patient With Hydrocephalus
- Comparison of Optic Nerve Sheath Diameter on Retrobulbar Ultrasound Before and After Drainage of Cerebrospinal Fluid in Patient With Hydrocephalus
- Comparison of Programmable and Non-programmable CSF Shunts Among Adult Hydrocephalus Patients With Different Etiologies
- CRT ShuntCheck “Fit & Function” Study
- Danish RAndomized Trial of External Ventricular Drainage Cessation IN Aneurysmal Subarachnoid Haemorrhage
- Diagnosing Malfunctioning Hydrocephalic Shunt Valves With a Flow Sensor
- Early Ventriculo-peritoneal Shunt in Subarachnoid Patients With External Ventricular Drainage
- Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage
- Efficacy Study of Hydrocephalus Surgery by Methods of Neuroelectrophysiology
- Endoscopic Third Ventriculostomy for Adults: A Prognostic Model for Success
- ETV Versus Shunt Surgery in Normal Pressure Hydrocephalus
- EVD Drainage Data and Intracranial Pressure (ICP) Measurements
- Expanded Access Protocol: Umbilical Cord Blood Infusions for Children With Brain Injuries
- Guided Application of Ventricular Catheters
- HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
- Hydrocephalus iPad-App Based Intervention Study
- Hyperfine Portable MRI in Hydrocephalus
- Impact of Ventricular Catheter Used With Antimicrobial Agents on Patients With a Ventricular Catheter
- Improvement of Peritoneal Catheter Placement in VPS With a Splitable Trocar
- Intraoperative Ultrasound Guided Compared to Stereotactic Navigated Ventriculoperitoneal Shunt Placement
- Intraoral 30% Glucose Effect In Newborns
- Intraventricular Drain Insertion: Comparison of Ultrasound-guided and Landmark-based Puncture of the Ventricular System
- Isoflurane-induced Neuroinflammation in Children With Hydrocephalus
- Linking Digital Smartphone Behaviour With Brain Function
- Magnetic Resonance Elastography in Hydrocephalus
- Monitoring Patient Cerebro-Spinal Fluid Drainage With an Ultrasonic Flow Sensor
- MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics
- Multimodal Investigation in the Diagnosis and Treatment of Chronic Adult Hydrocephalus
- NIMIP: Non Invasive Measurement of the Intracranial Pressure
- NIRS Monitoring in Premature Infants
- Non-invasive Epicutaneous Transfontanel Intracranial Pressure Monitoring in Children Under the Age of One: a Novel Technique
- Noninvasive Intracranial Pressure and Hydrocephalus Patients
- Optimizing Treatment of Post-hemorrhagic Ventricular Dilation in Preterm Infants
- Pilot Study to Evaluate the CereVasc® eShunt® System
- Pilot Study to Evaluate the CereVasc® eShunt® System in the Treatment of Communicating Hydrocephalus
- Prediction Model of Improvement of Disturbance of Consciousness in Patients With Hydrocephalus After Shunt Operation
- Prophylactic Antibiotics Useful With Antibiotic Impregnated External Ventricular Drains (EVDs)?
- Pupillometry : Predictive Indicator in External Ventricular Drain Clamping ?
- Quality of Life in Elderly After Aneurysmal Subarachnoid Hemorrhage (SAH)
- Quantitative Characterization of Safe Irrigation for Ventricular Shunt Catheters
- Quantitative Pupillometry
- Role of Proteomics and Metallomics in Cerebral Vasospasm Following Subarachnoid Hemorrhage
- Safety and Performance of the Polaris® 24 Adjustable Valve System in Hydrocephalus Patients’ Treatment
- ShuntCheck Versus Radionuclide in Evaluating Shunt Function in Symptomatic NPH Patients
- Simulation Efficacy in Neurosurgical Education
- Sonographic Monitoring of Weaning of Cerebrospinal Fluid Drainages
- Strata Programmable CSF Shunt Valve Study
- Study of Choroid Plexus Cauderization in Patients With Hydrocephalus
- Study of Shunt Flow Sensor Accuracy in Extra-ventricular Drains.
- Study of Ultrasound of the Eye for Children With Suspected Shunt Failure
- Subgaleal Drains in Decompressive Craniectomies
- Tablet-guided Versus Freehand (Tab-Guide) Ventriculostomy : Study Protocol to the Test Accuracy of Ventriculostomy in a Randomized Controlled Trial
- The CSF Shunt Entry Site Trial
- The ETCHES I Study (Endovascular Treatment of Communicating Hydrocephalus With an Endovascular Shunt)
- The Prediction of Intracranial Pressure and Clinical Outcome by Transcranial Doppler in Neurocritical Patients
- The Role of Neurofilament Light (NfL) in Patients With Hydrocephalus: A Pilot Study
- Thermal Camera Detection of Ventriculoperitoneal Shunt Flow
- Three-step Disinfection Reduce the Postoperative Infection Rate of Ventriculoperitoneal Shunt
- US Pilot Study to Evaluate the CereVasc® eShunt® System
- Value of MRI CSF Flowmetry in Assessment of Grey Zone Hydrocephalic Patients
- Ventricular Size Involvement in Neuropsychological Outcomes in Pediatric Hydrocephalus